We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

Back to rankings

84 hedge funds and large institutions have $145M invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79% less call options, than puts

Call options by funds: $623K | Put options by funds: $2.97M

Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
84
Increased
–
Reduced
–
Closed
–
Calls
$623K
Puts
$2.97M
Net Calls
-$2.34M
Net Calls Change
-$2.34M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$21M +$19.1M +2,589,356 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$14M +$12.8M +1,728,555 New
First Eagle Investment Management
3
First Eagle Investment Management
New York
$13.6M +$12.4M +1,672,487 New
BFA
4
BlackRock Fund Advisors
California
$11.2M +$10.2M +1,378,681 New
UBS AM
5
UBS AM
Illinois
$9.19M +$8.36M +1,132,270 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.36M +$4.87M +659,415 New
HCM
7
Harvey Capital Management
Florida
$4.45M +$4.06M +549,850 New
BIT
8
BlackRock Institutional Trust
California
$3.79M +$3.46M +468,510 New
State Street
9
State Street
Massachusetts
$3.56M +$3.24M +438,104 New
Axa
10
Axa
France
$3.51M +$3.19M +432,496 New
Northern Trust
11
Northern Trust
Illinois
$3.49M +$3.19M +431,308 New
BC
12
Broadfin Capital
New York
$3.28M +$2.99M +404,427 New
Bank of America
13
Bank of America
North Carolina
$2.56M +$2.33M +315,632 New
Wells Fargo
14
Wells Fargo
California
$2.45M +$2.24M +302,720 New
Deutsche Bank
15
Deutsche Bank
Germany
$2.34M +$2.13M +288,885 New
BB
16
BB Biotech
Switzerland
$2.27M +$2.07M +280,000 New
EI
17
EAM Investors
California
$2.2M +$2M +270,881 New
TC
18
TFS Capital
Pennsylvania
$1.91M +$1.74M +235,592 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$1.84M +$1.68M +227,272 New
RFC
20
Russell Frank Company
Washington
$1.72M +$1.64M +222,427 New
TCIM
21
TIAA CREF Investment Management
New York
$1.71M +$1.56M +210,604 New
HCM
22
Highbridge Capital Management
New York
$1.7M +$1.55M +209,816 New
Morgan Stanley
23
Morgan Stanley
New York
$1.58M +$1.44M +194,492 New
Millennium Management
24
Millennium Management
New York
$1.53M +$1.4M +189,135 New
JP Morgan Chase
25
JP Morgan Chase
New York
$1.26M +$1.15M +155,184 New
1
2 3 4

TSRX Hedge Fund Activity: Q2 2013 in Review

84 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q2 2013, worth a combined $145M.

Buyers outnumbered sellers: 84 funds opened new TSRX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $145M of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q2 2013.
  • 84 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.